Outlook Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in trillions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Outlook Therapeutics, Inc. (OTLK) - Annual data in trillions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018
Current Assets
Cash and Cash Equivalents8.080.000.000.000.000.000.000.00
Cash & Short-Term Investments8.080.000.000.000.000.000.000.00
Accounts Receivable0.000.000.000.000.000.000.000.00
Inventory3.340.000.000.000.000.000.000.00
Other Current Assets5.970.000.000.000.000.000.000.00
Total Current Assets17.390.000.000.000.000.000.000.00
Non-Current Assets
Property, Plant & Equipment (Net)0.230.000.000.000.000.000.000.00
Long-Term Investments0.000.000.000.000.000.000.000.00
Other Non-Current Assets0.970.000.000.000.000.000.000.00
Total Non-Current Assets1.200.000.000.000.000.000.000.00
Total Assets18.580.000.000.000.000.000.000.00
Current Liabilities
Accounts Payable10.190.000.000.000.000.000.000.00
Short-Term Debt0.060.000.000.000.000.000.000.00
Current Portion of Long-Term Debt0.000.000.000.000.000.000.000.00
Accrued Liabilities0.000.000.000.000.000.000.000.00
Other Current Liabilities35.260.000.000.000.000.000.000.00
Total Current Liabilities45.810.000.000.000.000.000.000.00
Non-Current Liabilities
Long-Term Debt0.190.000.000.000.000.000.000.00
Other Non-Current Liabilities4.770.000.000.000.000.000.000.00
Total Non-Current Liabilities4.960.000.000.000.000.000.000.00
Total Liabilities50.770.000.000.000.000.000.000.00
Stockholders' Equity
Common Stock0.540.000.000.000.000.000.000.00
Retained Earnings-605.710.000.000.000.000.000.000.00
Additional Paid-in Capital0.000.000.000.000.000.000.000.00
Shares Outstanding0.000.000.000.000.000.000.000.00
Total Stockholders' Equity-32.190.000.000.000.000.000.000.00
Total Liabilities & Equity18.580.000.000.000.000.000.000.00